Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Indian Journal of Otolaryngology and Head & Neck Surgery
Published in: Indian Journal of Otolaryngology and Head & Neck Surgery 3/2021

01-09-2021 | Vestibular Schwannoma | Clinical Report

Neurofibromatosis 2: Primary Modality of Hearing Rehabilitation with Cochlear Implant

Authors: Dathathri Anantaramaiah Halyur, Praveen H. Rayanagoudar, Apurva Kumar, Sunil Narayan Dutt

Published in: Indian Journal of Otolaryngology and Head & Neck Surgery | Issue 3/2021

Login to get access

Abstract

Auditory Brainstem Implants have been recommended as the gold standard in hearing rehabilitation of Neurofibromatosis Type 2 patients who lose hearing completely in both the ears and the cochlear nerves are not stimulable. Some patients have undergone cochlear implantation, in whom the cochlear nerve was spared during surgery or have undergone stereotactic radiotherapy preserving the function of the cochlear nerve. Here we report a case in whom we chose cochlear implantation prior to any definitive treatment for the tumour itself during the ‘wait and watch’ period. The reasons in favour of this approach have been discussed in this article. Post switch-on the implant is benefitting the patient satisfactorily and she is on regular follow up for monitoring the bilateral tumours.
Literature
1.
Evans DG (2009) Neurofibromatosis 2 Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II. Genet Med 11:599CrossRef
2.
Dutt SN, Kumar A (2019) The methodology and electro-physiological classification of pre-operative trans-tympanic electrically-evoked auditory brainstem response (TT-EABR). Indian J Otolaryngol Head Neck Surg 71:1–4CrossRef
3.
Archbold S, Lutman M, Marshall DH (1995) Categories of auditory performance. Ann Otol Rhinol Laryngol 166:312–314
4.
Allen MC, Nikolopoulos TP, O’Donoghue GM (1998) Speech intelligibility in children after cochlear implantation. Am J Otol 19:742–746PubMed
5.
Linthicum H, Brackmann DE (1980) Bilateral acoustic tumours. A diagnostic and surgical challenge. Arch Otolaryngol 106(12):729–733CrossRef
6.
Abaza MM, Makariou E, Armstrong M, Lalwani AK (1996) Growth rate characteristics of acoustic neuromas associated with neurofibromatosis type 2. Laryngoscope 106:694CrossRef
7.
Asthagiri AR et al (2012) Mechanisms of hearing loss in neurofirbomatosis type 2. PLoS ONE 7(9):e46132 Epub 2012 Sep 26CrossRef
8.
Hoffman RA, Kohan D, Cohen NL (1992) Cochlear implants in the management of bilateral acoustic neuromas. Am J Otol 13:525–528PubMed
9.
Dewan R, Pemov A, Kim HJ et al (2015) Evidence of polyclonality in neurofibromatosis type 2-associated multilobulated vestibular schwannomas. Neuro Oncol 17:566CrossRef
10.
Masuda A, Fisher LM, Oppenheimer ML et al (2004) Hearing changes after diagnosis in neurofibromatosis type 2. Otol Neurotol 25:150CrossRef
11.
Carlson ML, Breen JT, Driscoll CL, Link MJ, Neff BA, Gifford RH et al (2012) Cochlear implantation in patients with Neurofibromatosis type 2: variables affecting auditory performance. Otol Neurotol 33:853–862CrossRef
12.
Lambert PR, Ruth RA, Thomas JF (1992) Promontory electrical stimulation in postoperative acoustic tumour patients. Laryngoscope 102(7):814–819CrossRef
13.
Cueva RA, Thedinger BA, Harris JP, Glasscock ME (1992) Electrical promontory stimulation in patients with intact cochlear nerve and anacusis following acoustic neuroma surgery. Laryngoscope 102(11):1220–1224CrossRef
14.
Neff BA, Wiet RM, Lasak JM et al (2007) Cochlear implantation in the neurofibromatosis type 2 patient: long-term follow-up. Laryngoscope 117(6):1069–1072CrossRef
15.
Vincenti V, Pasanisi E, Guida M, Di Trapani G, Sanna M (2008) Hearing rehabilitation in neurofibromatosis type 2 patients: cochlear versus auditory brainstem implantation. Audiol Neurotol 13(4):273–280CrossRef
16.
Kida Y, Kobayashi T, Tanaka T, Mori Y (2000) Radiosurgery for bilateral neurinomas associated with neurofibromatosis type 2. Surg Neurol 53:383CrossRef
17.
Mathieu D, Kondziolka D, Flickinger JC et al (2007) Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: an analysis of tumor control, complications, and hearing preservation rates. Neurosurgery 60:460CrossRef
18.
Samii M, Matthies C, Tatagiba M (1997) Management of vestibular schwannomas (acoustic neuromas): auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2. Neurosurgery 40:696–706CrossRef
19.
Balasubramaniam A, Shannon P, Hodaie M et al (2007) Glioblastoma multiforme after stereotactic radiotherapy for acoustic neuroma: case report and review of the literature. Neuro Oncol 9:447CrossRef
20.
Wackym PA, Runge-Samuelson CL, Nash JJ et al (2010) Gamma knife surgery of vestibular schwannomas: volumetric dosimetry correlations to hearing loss suggest stria vascularis devascularization as the mechanism of early hearing loss. Otol Neurotol 31(9):1480–1487CrossRef
21.
Crane BT, Gottschalk B, Kraut M, Aygun N, Niparko JK (2010) Magnetic resonance imaging at 1.5 T after cochlear implantation. Otol Neurotol 31(8):1215–1220CrossRef
22.
Gubbels SP, McMenomey SO (2006) Safety study of the cochlear nucleus #24 device with internal magnet in the 1.5 Tesla magnetic resonance imaging scanner. Laryngoscope 116(6):865–871CrossRef
23.
Baumann R, Lesinski-Schiedat A, Goldring JE et al (1999) The influence of ionizing radiation on the CLARION 1.2 cochlear implant during radiation therapy. Am J Otol 20(1):50–52PubMed
24.
Ralston A, Stevens G, Mahomudally E, Ibrahim I, Leckie E (1999) Cochlear implants: response to therapeutic irradiation. Int J Radiat Oncol Biol Phys 44(1):227–231CrossRef
25.
Klenzner T, Knapp F, Rohner F et al (2005) Influence of ionizing radiation on nucleus 24 cochlear implants. Otol Neurotol 26(4):661–667CrossRef
Metadata
Title
Neurofibromatosis 2: Primary Modality of Hearing Rehabilitation with Cochlear Implant
Authors
Dathathri Anantaramaiah Halyur
Praveen H. Rayanagoudar
Apurva Kumar
Sunil Narayan Dutt
Publication date
01-09-2021

Other articles of this Issue 3/2021

Indian Journal of Otolaryngology and Head & Neck Surgery 3/2021 Go to the issue

Original Article

The Test of Masticating and Swallowing Solids (TOMASS): Reliability, Validity and Normative Data for the Adult Indian Population

Original Article

Role of Immediate Pre-Operative Tympanometry in Cochlear Implantation: MERF Protocol and Experience

Original Article

Surgical Management of Bilateral Abductor Palsy: Comparative Study Between Posterior Cordotomy and Partial Arytenoidectomy

Original Article

Utility of Microhemorrhage as a Diagnostic Tool in Distinguishing Vestibular Schwannomas from other Cerebellopontine Angle (CPA) Tumors

Clinical Report

Cochlear Implantation in Pierre Robin Syndrome

Original Article

Correlation Between Anosmia and Severity Along with Requirement of Tocilizumab in COVID-19 Patients